+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Metastatic Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Metastatic Pancreatic Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Pancreatic Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Metastatic Uveal Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Uveal Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Mouth Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Mouth Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
FGFRpositive Gastroesophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

FGFRpositive Gastroesophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2024 - Product Thumbnail Image

Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Urothelial Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Urothelial Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Oligodendroglioma - Pipeline Insight, 2024 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Familial Adenomatous Polyposis Coli - Pipeline Insight, 2024 - Product Thumbnail Image

Familial Adenomatous Polyposis Coli - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Metastatic Liver Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Liver Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Medulloblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Medulloblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Medullary Thyroid Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Medullary Thyroid Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Nasopharyngeal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Nasopharyngeal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Myelofibrosis - Pipeline Insight, 2024 - Product Thumbnail Image

Myelofibrosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Mycosis Fungoides - Pipeline Insight, 2024 - Product Thumbnail Image

Mycosis Fungoides - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more